ADBA Dental Anesth flashcards
ADBA Dental Anesth · Build recall with a focused review session.
31 cards. Read the term and the definition here. The deck at the top of this page is optional.
- MAC definition
- The end-tidal concentration of an inhaled anesthetic at which 50% of patients do not move to a standardized surgical stimulus; it is inversely proportional to potency.
- MAC additivity
- When volatile agents are combined, their MAC fractions are additive; 0.5 MAC of one agent plus 0.5 MAC of another approximates 1.0 MAC total.
- Local anesthetic maximum dose
- The maximum recommended mg/kg dose limits systemic toxicity; for lidocaine with epinephrine it is 7 mg/kg, and absolute mg = % concentration × 10 × mL.
- pKa and onset
- Anesthetic pKa relative to physiologic pH determines the fraction of uncharged base available to cross the nerve membrane; pKa closest to 7.4 gives the fastest onset.
- Protein binding and duration
- The degree of plasma protein binding of a local anesthetic correlates with its duration of action; highly bound agents such as bupivacaine last longer.
- ASA Physical Status I-VI
- A six-tier perioperative risk classification (I = healthy, VI = brain-dead organ donor); the 'E' suffix denotes emergency surgery and elevates risk.
- Malignant hyperthermia antidote
- Dantrolene sodium 2.5 mg/kg IV titrated is the specific treatment for MH, a RYR1-mediated hypermetabolic crisis triggered by volatile agents and succinylcholine.
- BIS target range
- Bispectral index monitoring of anesthetic depth; a value of 40-60 corresponds to adequate general anesthesia and reduces awareness risk.
- End-tidal CO2 target
- Capnography measures exhaled CO2; a normal end-tidal value of 35-45 mmHg confirms adequate ventilation and tube placement.
- Mallampati classification
- A four-class airway assessment based on oropharyngeal visibility; Class III-IV predicts difficult laryngoscopy and intubation.
- Succinylcholine dose
- A depolarizing neuromuscular blocker given at 1-1.5 mg/kg IV for rapid sequence intubation; it is contraindicated in malignant hyperthermia susceptibility and hyperkalemia.
- Propofol induction dose
- An IV induction agent dosed at 1.5-2.5 mg/kg; it causes hypotension and apnea and requires airway support and monitoring.
- Ketamine dose
- A dissociative anesthetic at 1-2 mg/kg IV or 4-6 mg/kg IM; it preserves airway reflexes and respiratory drive but can cause emergence reactions.
- Midazolam dose
- A short-acting benzodiazepine at 0.05-0.1 mg/kg IV for sedation and anxiolysis; flumazenil 0.2 mg IV titrated reverses its effect.
- NPO fasting intervals
- ASA fasting guidance: 2 hours for clear liquids, 4 hours for breast milk, 6 hours for light meals and non-human milk, 8 hours for fatty meals.
- Nitrous oxide MAC
- Nitrous oxide has a MAC of approximately 105%, so it cannot produce surgical anesthesia alone at 1 atm but is used as an adjunct and for analgesia.
- Case-defense problem list
- The oral exam opening: state ASA class, airway assessment, comorbidities, and procedure invasiveness before proposing the anesthetic technique.
- Difficult airway plan
- For a predicted difficult airway, defend awake fiberoptic or videolaryngoscopy intubation, RSI with cricoid pressure, and a clearly stated rescue algorithm.
- Pediatric sedation justification
- Match agent (nitrous oxide, midazolam, ketamine, propofol) to the child's cooperation, fasting status, and procedure length, with pulse oximetry and capnography monitoring.
- LAST recognition
- Local anesthetic systemic toxicity presents with perioral numbness, tinnitus, seizures, and cardiovascular collapse; it requires airway support and lipid emulsion therapy.
- Lipid emulsion dosing
- For LAST, give 20% lipid emulsion 1.5 mL/kg IV bolus followed by 0.25 mL/kg/min infusion, repeated as needed until hemodynamic stability.
- Anticoagulant management
- Timing of dental extraction and regional blocks is defended by drug half-life: hold DOACs 24-48 hours and avoid deep blocks when bleeding risk is high.
- OSA case planning
- For obese or OSA patients, defend preoxygenation, ramped positioning, opioid-sparing analgesia, and extended post-anesthesia monitoring with continuous pulse oximetry.
- Anaphylaxis preparedness
- For patients with latex or antibiotic allergy, defend latex-free setup, H1/H2 blockers and steroids premedication, and epinephrine 0.3-0.5 mg IM ready.
- Cardiac patient anesthesia
- In severe aortic stenosis, avoid epinephrine-containing local anesthetics; defer elective care six months after MI and use bipolar cautery with pacemakers.
- Aldrete discharge score
- A post-anesthesia recovery score based on activity, respiration, circulation, consciousness, and oxygen saturation; a score of 9 or higher supports discharge.
- Informed consent for sedation
- The oral case defense must state that risks, benefits, and alternatives of sedation or anesthesia were discussed and documented before the procedure.
- Inferior alveolar block risk
- Deep blocks such as the inferior alveolar and pterygomandibular carry bleeding and nerve injury risk, so they are avoided in coagulopathic patients.
- RSI indication
- Rapid sequence intubation with cricoid pressure is defended for patients at high aspiration risk or with a full stomach before emergency dental anesthesia.
- Rescue airway algorithm
- The contingency plan in a case defense: state the sequence of mask ventilation, supraglottic airway, videolaryngoscopy, and surgical airway if intubation fails.
- Epinephrine in local anesthetic
- Vasoconstrictor in local anesthetic prolongs duration and reduces bleeding; it is avoided in severe aortic stenosis and uncontrolled hypertension.